World's Best Scientists 2026 revealed!
Ernest C. Borden

Ernest C. Borden

D-Index & Metrics

Biology and Biochemistry

D-Index
91
Citations
31216
World Ranking
2314
National Ranking
1239

Medicine

D-Index
92
Citations
32102
World Ranking
11279
National Ranking
5791

Ernest C. Borden publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ernest C. Borden sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 404 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ernest C. Borden D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ernest C. Borden sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 91 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2008 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Ernest C. Borden is affiliated with the Cleveland Clinic in the United States. Their research focuses primarily on the fields of Medicine, with specific work in Oncology and Infectious Diseases. The main topics covered in their work include COVID-19 and healthcare impacts, COVID-19 clinical research studies, and cancer immunotherapy and biomarkers.

Borden has published research in notable venues, including the Journal for ImmunoTherapy of Cancer. One of their recent papers, published in 2020, is titled Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19, which contributes to understanding immuno-oncology and therapeutic access during the pandemic.

Frequent co-authors collaborating with Borden include:

  • Paolo A. Ascierto
  • Bernard A. Fox
  • Walter J. Urba
  • Ana C. Anderson
  • Michael B. Atkins

Borden has explored topics that intersect cancer treatment and infectious disease responses, particularly in the context of COVID-19. Their contributions address both clinical research studies related to COVID-19 and biomarker development in cancer immunotherapy.

In recognition of their contributions to science, Ernest C. Borden was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2008.

Best Publications

  • Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

    John M. Kirkwood;Myla Hunt Strawderman;Marc S. Ernstoff;Thomas J. Smith

  • Interferons at age 50: past, current and future impact on biomedicine.

    Ernest C Borden;Ganes Sen;Gilles Uze;Robert H Silverman

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.

    Mamta Chawla-Sarkar;Daniel J Lindner;Y-F Liu;Bryan Raymond George Williams

  • Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

    G. Thomas Budd;Massimo Cristofanilli;Mathew J. Ellis;Allison Stopeck

  • Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

    Michael C. Heinrich;Kouros Owzar;Christopher L. Corless;Donna Hollis

  • Inhibition of Angiogenesis by Interferons: Effects on Tumor-and Lymphocyte-induced Vascular Responses

    Younan A. Sidky;Ernest C. Borden

  • Biological Properties of Recombinant α-Interferons: 40th Anniversary of the Discovery of Interferons

    Lawrence M. Pfeffer;Charles A. Dinarello;Ronald B. Herberman;Bryan R. G. Williams

  • Soft Tissue Sarcomas of Adults State of the Translational Science

    Ernest C. Borden;Laurence H. Baker;Robert S. Bell;Vivien Bramwell

  • Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

    Xiaoxia Z. West;Nikolay L. Malinin;Alona A. Merkulova;Mira Tischenko

  • Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.

    M Chawla-Sarkar;S I Bae;F J Reu;B S Jacobs

  • IMMUNOREGULATORY PROPERTIES OF ISG15, AN INTERFERON-INDUCED CYTOKINE

    Jonathan D'Cunha;Ernest Knight;Arthur L. Haas;Robert L. Truitt

  • Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

    Baisakhi Raychaudhuri;Patricia Rayman;Joanna Ireland;Jennifer Ko

  • Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

    E C Borden;D A Amato;C Rosenbaum;H T Enterline

  • Interferons α and β in cancer: therapeutic opportunities from new insights.

    Ernest C Borden

  • Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.

    Mamta Chawla-Sarkar;Douglas W. Leaman;Ernest C. Borden

  • Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients

    Thomas F. Hogan;Ernest C. Borden;J. A. McBAIN;B. L. Padgett

  • High-throughput Immunoblotting UBIQUITIN-LIKE PROTEIN ISG15 MODIFIES KEY REGULATORS OF SIGNAL TRANSDUCTION

    Michael P. Malakhov;Keun Il Kim;Oxana A. Malakhova;Barbara S. Jacobs

  • In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine.

    Jonathan D'Cunha;Sujatha Ramanujam;Randall J. Wagner;Patricia L. Witt

  • Inhibition of Murine Tumor Growth by an Interferon-inducing Imidazoquinolinamine

    Younan A. Sidky;Ernest C. Borden;Charles E. Weeks;Michael J. Reiter

Frequent Co-Authors

Joan H. Schiller
Joan H. Schiller University of Virginia
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Gerald I. Byrne
Gerald I. Byrne University of Tennessee Health Science Center
David Goldstein
David Goldstein University of New South Wales
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Paul M. Sondel
Paul M. Sondel University of Wisconsin–Madison
Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Charles D. Blanke
Charles D. Blanke Oregon Health & Science University
James K V Willson
James K V Willson The University of Texas at Dallas
Robert S. Benjamin
Robert S. Benjamin The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Biology and Biochemistry majors have a wide range of related online degree and certificate pathways to explore in today’s flexible education landscape. If you’re interested in the intersection of science, healthcare, and data, earning a HIM degree (Health Information Management) can pave the way for roles in medical records and health data management.

For those seeking a career focused on the technical side of healthcare, consider learning is medical coding a good career. Medical billing and coding professionals are vital to healthcare systems and often have remote work opportunities.

If nutrition interests you, several online master’s degree in nutrition programs are available. These can lead to careers as a registered dietitian or nutritionist, both in clinical and non-clinical settings.

Technology-focused students may also consider online sonography certificate programs, which prepare graduates to become ultrasound or medical imaging specialists, a field with strong job prospects. These online pathways offer flexible options for those looking to advance their biology and biochemistry expertise into growing healthcare areas.

Best Scientists Citing Ernest C. Borden

Trending Scientists

Recently Published Articles